Richard Brook, President of Cochlear Europe, Middle East & Africa, welcomed attendees to the Monsana Conference in St. Petersburg. Cochlear is a global leader in implantable hearing solutions, including cochlear implants, Baha systems, and hybrid devices. With over 2,000 employees and products sold in over 100 countries, Cochlear invests 13% of sales in R&D and has an estimated 70% market share of the cochlear implant market, serving over 120,000 recipients worldwide. Cochlear's focus areas presented were continuing to improve hearing performance, developing smaller and better processors, simplifying the process for professionals, ensuring patients can use new technologies, and setting new standards of product reliability.

1. Monsana Conference, St. Petersburg:
Cochlear Presentation
Richard Brook
President
Cochlear Europe, Middle East & Africa

2. Welcome & Thank You
Dr. Dr. Monika Lehnhardt
Professor Nakatis
Professor George Tavartkiladze
Professor Yanov
Professor Daikhes

3. Leader in implantable devices for hearing impaired:
1. Cochlear implants (CI)
2. Baha®
3. Electro-Acoustic Stimulation (HybridTM)
4. Direct Acoustic Cochlear Stimulator (DACS)
Global company with focus on innovation
~ 2,000 employees & products sold in 100+ countries
~ 13% of sales spent on R&D, (est) CI market share of 70%
120,000 CI recipients
Cochlear : Background

4. gf
The Portable Speech Processor PSP-2 - 1980

5. Nucleus/Cochlear Clinical Trial 1982-85

6. 1991

7. Cochlear s Focus Areas
1. Continue to improve hearing performance
2. Smaller, better, easier processors
3. Simplify for professionals
4. Make sure patients can use new technology
5. Set new standards in product reliability

8. Correct(%)
0
20
40
60
80
100
Words
Key words in Sentences
n = 16
n = 45
n = 32
n = 148
n = 77
Strategy:
Year:
F0/F2
1978
F0/F1/F2
1979-80
Multispeak
1989
SPEAK
1991
ACE
1998
Mean Open-Set Scores
(Adults, electrical stimulation alone at 3 months. Tests in English)

9. Freedom for Adults:- outstanding
performance in quiet and noise
Significant increase in scores post-operatively
Continuing improvement shown over 12
months

10. Very Young Language Outcomes:
0
1
2
3
0 1 2 3 4
Chronological Age (years)
EquivalentLanguageAge
(years)
Dettman, et al., 2006, in press

11. Very Young Language Outcomes:
Group A, CI 12 months (N=11)
Individual growth rates for children with 2 or more administrations of
receptive language subscale of RI-TLS
0
1
2
3
0 1 2 3 4
Chronological Age (years)
EquivalentLanguageAge
(years)
Dettman, et al., 2006, in press

12. Cochlear s Focus Areas
1. Continue to improve hearing performance
2. Smaller, better, easier processors!
3. Simplify for professionals
4. Make sure patients can use new technology
5. Set new standards in product reliability

13. Sound Processors
Smaller Sound Processors

14. Helping people stay connected
Wireless Connectivity

15. Future = no sound processors!
Invisible HearingTiki - Totally
Implantable
Research CI
Integrated
Implantable
Microphone
Integrated
Digital Signal
Processor
Integrated
Rechargeable
Battery

16. Cochlear s Focus Areas
1. Continue to improve hearing performance
2. Smaller, better, easier processors!
3. Simplify for professionals
4. Make sure patients can use new technology
5. Set new standards in product reliability

17. Simplification for clinicians
Simple fitting methods for
routine fitting

18. Addressing daily life in Russia
Remote Recipient Fitting &
Follow-up
Internet
Cochlear
Clinic /
Fitting Centre

19. Cochlear s Focus Areas
1. Continue to improve hearing performance
2. Smaller, better, easier processors!
3. Simplify for professionals
4. Make sure patients can use new technology
5. Set new standards in product reliability

20. Recipient access to latest technology
CI24RE
Freedom
CI24M CI22CI24R

21. Cochlear s Focus Areas
1. Continue to improve hearing performance
2. Smaller, better, easier processors!
3. Simplify for professionals
4. Make sure patients can use new technology
5. Set new standards in product reliability

22. Set benchmarks in product reliability

23. Years
0 1 2 3 4 5 6 7 8
0
1
2
3
Nucleus Freedom
Reliability is important !
Cochlear:
Competitor A
Competitor B
1 Publication: Nucleus Reliability Report, Vol. 5, June 2008.
2 Publication: Advanced Bionics - Auditory Reliability Report, Summer 2008.
3 MED-EL Website: http://www.medel.at/english/30_Products/01_MAESTRO/pulsar/Pulsar.htm (October 2008)
WorseBetter
Public data
from company
websites
Competitor A
Competitor A
Competitor B
Old
B New
Competitor Competitor A

24. Reliability does not happen by chance!!

25. Key Points Summary
Cochlear s Commitment to helping the hearing impaired
Leader in Implantable Hearing Solutions
R&D for Russia Today
1. Continue to improve hearing performance
2. Smaller, better, easier processors!
3. Simplify for professionals
4. Make sure patients can use new technology
5. Set new standards in product reliability

26. !!